You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

104 Results
Guidelines and Advice
Status: Current
Version: 1
Mar 2018
Guidelines and Advice
Status: In-Review
ID: 6-13
Mar 2018
Guidelines and Advice
Status: Current
Apr 2018
Cancer facts
Apr 2018
Guidelines and Advice
Status: Archived
ID: GL 11-12
Apr 2018
Cancer facts
Jul 2018
Guidelines and Advice
Status: Current
ID: PET 2017-2
Version: n/a
May 2018
Regimen
Cancer Type:
Hematologic, 
Lymphoma - T-cell
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative
Funding:
ODB - General Benefit
    prednisone
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
prednisone,
DOXOrubicin,
vinCRIStine,
cyclophosphamide
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
May 2018
Guidelines and Advice
Status: Current
May 2018
Cancer facts
Aug 2018
Guidelines and Advice
Status: Current
ID: ES SMG-2
Jun 2018
Guidelines and Advice
Status: Current
ID: GL END 2-31
Jul 2018

Pages